Cyclic AMP (cAMP) regulates a number of eukaryotic genes by mediating the protein kinase A (PKA)-dependent phosphorylation of the CREB transcription factor at Ser-133. In this study, we test the hypothesis that the stoichiometry and kinetics of CREB phosphorylation are determined by the liberation and subsequent translocation of PKA catalytic subunit (C subunit) into the nucleus. Using fluorescence imaging techniques, we observed that PKA was activated in a stimulus-dependent fashion that led to nuclear entry of C subunit over a 30-min period. The degree of CREB phosphorylation, assessed with antiserum specific for CREB phosphorylated at Ser-133, correlated with the amount of PKA liberated. The time course of phosphorylation closely paralleled the nuclear entry of the catalytic subunit. There was a linear relationship between the subsequent induction of the cAMP-responsive somatostatin gene and the degree of CREB phosphorylation, suggesting that each event-kinase activation, CREB phosphorylation, and transcriptional induction-was tightly coupled to the next. In contrast to other PKA-mediated cellular responses which are rapid and quantitative, the slow, incremental regulation of CREB activity by cAMP suggests that multifunctional kinases like PKA may coordinate cellular responses by dictating the kinetics and stoichiometry of phosphorylation for key substrates like CREB.
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Many growth factors and hormones regulate cellular activity through second messengers which correspondingly induce multifunctional protein kinases. For example, the cyclic AMP (cAMP)-dependent protein kinase A (PKA) regulates a number of cellular processes, including motility, metabolism, neurotransmitter release, and transcription, by the reversible phosphorylation of key substrates. Remarkably, these pathways converge on the same regulatory kinase, PKA, yet they display distinct kinetics and sensitivities to cAMP-mediated stimuli. Adrenaline stimulates glycogen metabolism, for example, through a cAMP-driven cascade which allows the initial hormonal signal to be amplified about 1,000-fold at each enzymatic step (3) . This signal amplification promotes rapid on-off responses, as illustrated by the maximal activation of glycogen phosphorylase which occurs within 5 to 8 s of hormonal stimulation.
In contrast to the rapid induction seen with glycogen metabolism, cAMP-stimulated transcription proceeds at a far slower pace, with peak rates of transcription occurring only after 30 min (8, 11) . cAMP regulates the expression of specific genes by mediating the PKA-dependent phosphorylation of the CREB transcription factor at Ser-133 (6) . To explain the discrepancy between these two events, we developed a polyclonal antiserum directed against the phosphorylated form of CREB (phosphorylated at . This antiserum could readily discriminate between phosphorylated and dephosphorylated forms of the protein, thereby enabling us to assess the kinetics and stoichiometry of * Corresponding author.
CREB phosphorylation in response to extracellular signals. Instead of the all-or-none response expected for a signalamplifying mechanism, we found a linear relationship between the degree of CREB phosphorylation and the degree of hormonal stimulation. Unlike the rapid induction of glycogen-metabolizing enzymes by cAMP, the activation of CREB was very slow.
Microscopic imaging analysis of cells microinjected with fluorescently labeled PKA revealed that the nuclear translocation of C subunit was slow enough to be the rate-limiting step in the transcriptional response pathway. The amount of C-subunit activity translocated to the nucleus correlated with the strength of the hormonal stimulus. Our results suggest that the subcellular distribution of key PKA substrates may determine their relative sensitivities to hormonal stimulation.
MATERIALS AND METHODS
Antibody preparation. A CREB peptide containing residues 128 to 141 was synthesized and then purified by reversed-phase high performance liquid chromatography. The purified peptide was coupled to keyhole limpet hemocyanin by the method described by Vaughan et al. (16) and phosphorylated by incubation in a solution containing 10 ,ug of C subunit of PKA per ml, 1 mM ATP, 2 mM MgCl2, and 20 mM Tris-HCI (pH 7.0) at 30°C for 3 h. The coupled phosphopeptide (100 ,ug) was emulsified in Freund's complete adjuvant and injected subcutaneously into rabbits on a biweekly schedule. Rabbits were bled 6 weeks after the initial injection. Immunoglobulin G was precipitated from 4852 Vol. 13 The dotted vertical lines show when forskolin was applied to the cells. The top graph shows the ratio of PKA fluorescence intensity in the nucleus (N) versus that in cytoplasm (C), as determined by scanning confocal microscopy. The bottom graph shows the ratio of free C subunit to PKA holoenzyme, expressed as an emission ratio (515-nm wavelength/>560-nm wavelength) plotted against time.
VOL. 13, 1993 Phosphorylation assay. PKA activity was determined in a standard 5- For fluorescence measurements, cells were imaged on a custom-built video rate scanning confocal microscope. Energy transfer was measured by monitoring the ratio of fluorescence intensities at the emission wavelengths of fluorescein (515 + 14 nm) and rhodamine (>560 nm) compared with the 488-nm line on an argon ion laser. Each image was analyzed by drawing a circular spot over the area of interest and averaging the intensities as described previously (1) . Both the fluorescein and rhodamine emission intensities were collected, permitting us to determine the nuclear brightness/cytoplasmic brightness ratios of fluorescently labeled C subunit as well as fluorescein emission intensity/ rhodamine emission intensity ratios at fluorescein excitation wavelengths. Emission ratios were normalized to reflect the fraction of active kinase in cells. Maximum kinase activity was obtained by treating cells with 10 ,uM forskolin.
RESULTS
To evaluate PKA activation and nuclear translocation in response to cAMP, we microinjected PC12 cells with FICRhR, fluorescently labeled PKA holoenzyme (Fig. 1 translocation of C subunits proceeded steadily and reached a plateau at 30 min after stimulation. Under these conditions, the C subunit appeared to be concentrated 1.4-fold in the nucleus relative to the cytoplasm. The kinetics of C-subunit entry into the nucleus coincided with the previously described rates of CREB phosphorylation and CRE-dependent transcription in response to forskolin (8, 11) , with each becoming maximal after 30 min. The level of nuclear C subunit did not decrease in parallel with the drop in CREB phosphorylation which we previously observed after 1 h (8) but remained elevated for at least 50 min after forskolin stimulation.
To determine the amount of PKA available for phosphor- (3) . On the basis of the nuclear intensity/cytoplasmic intensity measurements we obtained with fluorescently labeled PKA, the concentration of free catalytic subunit in the nucleus should approach 1.2 to 1.7 ,uM after 30-min exposure to 10 p,M forskolin.
To monitor CREB phosphorylation in response to cAMP, we developed an antiserum specific for CREB phosphorylated at Ser-133 raised against a PKA-phosphorylated synthetic CREB peptide (aa 128 to 141). Immunoblot analysis (Fig. 2) revealed that the affinity-purified antiserum 5322 could discriminate between dephosphorylated and PKAphosphorylated CREB protein, whereas CREB antiserum 220 (7), raised against a synthetic CREB peptide spanning aa 136 to 150, could not. Antiserum 5322 could not detect PKA-treated CREB-Ml protein which contains a Ser-133-.Ala-133 substitution, suggesting that phosphorylation of Ser-133 was indeed critical for immunoreactivity.
To determine the selectivity of antiserum 5322 for phosphorylated CREB protein versus other cellular substrates of PKA, we examined crude extracts of rat hippocampus and hypothalamus by Western blot (immunoblot) analysis (Fig.  2) . It was remarkable that 5322 antiserum could indeed distinguish a single 43-kDa CREB band after but not before in vitro phosphorylation with PKA. In contrast, the nondiscriminating 244 CREB antiserum showed no preference for either form of the protein. Moreover, other CREB homologs, such as ATF-1 (39 kDa) and CREM (21 kDa) (5, 9), apparently did not cross-react with this antiserum, although we cannot exclude the possibility that the closely related cAMP-responsive factor CREMT (43 kDa) is not recognized by this antiserum.
To test whether the 5322 antiserum could detect CREB phosphorylation after induction by cAMP in living cells, we compared CREB immunoreactivity prior to and following treatment of PC12 pheochromocytoma cells with forskolin (Fig. 3) (Fig. 3D) .
The phosphorylated CREB-specific antiserum 5322 (Fig.  3C ) detected less than 1 ng of phosphorylated CREB per 20 ,ug of nuclear protein in control PC12 cells but recognized 3 to 4 ng of phosphorylated CREB per 20 ,ug of nuclear extract protein from forskolin-treated cells. Since in vitro PKAphosphorylated control nuclear extracts contained 8 ng of phosphorylated CREB per 20 ,ug of nuclear extract protein, all of the CREB protein in PC12 cells appears to be phosphorylatable, but only about 40% of total CREB is actually modified in response to forskolin stimulation.
To compare the cellular distribution and DNA-binding characteristics of CREB versus phosphorylated CREB prooCREB teins, we prepared cytoplasmic and nuclear extracts from BOUND both unstimulated and forskolin-treated PC12 cells (Fig. 4) Fig. 3C and D) . Detection of PKA phosphorylated CREB was linear from 0 to 10 ng for both antisera. Unphosphorylated CREB was recognized equally well by the nondiscriminating antiserum 244, but no signal was observed with the phosphorylated-CREBspecific antiserum 5322, as expected.
To determine the stoichiometry of CREB phosphorylation To determine the Km of PKA for the CREB phosphorylation site at Ser-133, we employed both full-length CREB protein and a synthetic CREB peptide (aa 128 to 141) (Fig.  5) . Remarkably, the Km value for CREB was 10 ,uM, far above the estimated nuclear concentration of the protein (400 nM). The same Km value (10 ,uM) was obtained with a 14-aa synthetic CREB peptide (aa 128 to 141), suggesting that this low Km was caused by the PKA phosphorylation site itself and not to steric hindrance from other regions of CREB. The PKA phosphorylation site (aa 130 to 134; Arg Arg Pro Ser Tyr) is followed by two basic residues, Arg-135 Lys-136, which have previously been characterized as potent negative regulators of PKA when located at +2 and +3 positions relative to the Ser phosphoacceptor (10) . These values are consistent with those reported by Colbran et al. (4) .
Although the affinity of PKA for CREB was low, the Vm.
for CREB phosphorylation was quite high (800 ,umol/min/ ,umol of enzyme) (Fig. 5) The high predicted rate of CREB phosphorylation prompted us to ask whether any stimulus might be sufficient to trigger near-quantitative phosphorylation of CREB. We examined CREB phosphorylation and CRE-CAT activity in NIH 3T3 cells treated with increasing concentrations of 8-Br-cAMP (Fig. 6A) . Western blot analysis revealed that CREB protein was actually phosphorylated in a dose-dependent manner, and the degree of phosphorylation after 30 min coincided with the relative induction of the somatostatin promoter, as determined by a transient assay. The phosphatase inhibitor okadaic acid had no effect on peak levels of CREB phosphorylation after 30 min (not shown), suggesting that the previously described protein phosphatase 1 (PP-1) attenuation of CREB (8) must occur later. In the absence of detectable PP-1 activity, the incremental phosphorylation of CREB should therefore reflect a corresponding dose-dependent increase in free nuclear C subunit.
To test this possibility, we measured the proportion of PKA holoenzyme dissociated after treatment of NIH 3T3 cells with various concentrations of 8-Br-cAMP (Fig. 6B) . dependent transcription. Thus, for example, 30% of maximal PKA activation (100 ,uM 8Br-cAMP) was accompanied by about 30% of maximal CREB phosphorylation and CRE-CAT induction at the same level of inducer.
To test whether receptor-mediated stimuli also regulate CREB activity through a slow, incremental mechanism, we treated PC12 cells with secretin. This hormone has previously been shown to stimulate tyrosine hydroxylase (TH) activity in PC12 cells through PKA-dependent phosphorylation of the enzyme within 8 to 10 s of treatment (14) . In contrast with the rapid activation of TH, CREB phosphorylation in response to secretin was far slower (30 to 60 min) and proceeded in a dose-dependent manner (Fig. 7) . CREB was phosphorylated at a threshhold dose of 1 to 2 nM secretin and became maximal at 100 nM secretin. Somatostatin promoter activity, as measured by a transient assay over a 5-h period, increased in a parallel fashion, suggesting that cAMP-dependent transcription was also tightly coupled to the strength of the extracellular stimulus.
DISCUSSION
Although the signal cascade paradigm has been useful in explaining rapid, quantitative induction of metabolic events, this model may be inappropriate for transcriptional processes which often display graded responses to hormones and growth factors. Three features, a low concentration of substrate (CREB protein), delayed transport of C subunit to the nucleus, and a low affinity of PKA for CREB, appear to promote a slow, graded transcriptional response to extracellular inducers relative to other cellular events.
Like other nuclear regulatory factors, CREB is expressed at low levels compared with other cellular proteins. PKA is far more abundant than CREB in PC12 cells, suggesting that Ser-133 phosphorylation must be a low-efficiency event in order to be incrementally regulated. In contrast, phosphorylase kinase, the first step in the glycogen cascade, is present at about 20-fold-higher concentrations (3) and theoretically would be phosphorylated about 25 times faster than CREB.
The time required for nuclear entry of PKA also contributes to the kinetic differences between cytoplasmic and nuclear events. Glycogen metabolism and neurotransmitter synthesis occur within seconds of stimulation with cAMP, but transcriptional events become maximal only after 30 min. Our results with the fluorescently labeled PKA holoenzyme suggest that the kinetics for transcriptional induction coincide with the time required for nuclear entry of free catalytic subunit. The lag period between such cytoplasmic and nuclear events may thus favor a prioritized set of responses to cellular inducers.
Having ventured into the nucleus after stimulation, the free C subunit does not rapidly exit into the cytoplasm or become noticeably associated with R subunit. The dephosphorylation of CREB in face of persistent nuclear C subunit (8) probably reflects competition between phosphorylating and dephosphorylating activities arising from PKA and PP-1, with PP-1 prevailing at later times. Indeed, Buellens et al. (2) have recently identified a nuclear inhibitor of PP-1, termed NIPP-1, which releases active PP-1 in response to PKA.
Phosphorylation of CREB did not appear to trigger expression of the somatostatin gene by recruitment of CREB onto DNA. Indeed, CREB retains full PKA responsiveness when fused to heterologous DNA-binding domains, suggesting that phosphorylation specifically regulates the activation domain of this protein (8, 12, 15 
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tivity through an incremental mechanism, and we attribute some proportion of this stimulus-dependent regulation to two basic residues C terminal to the PKA phosphorylation site, which have previously been shown to increase the apparent Km of PKA for such substrates as much as 100-fold (10). Our results suggest that multifunctional kinases like PKA may coordinate cellular responses to extracellular stimuli by regulating key substrates with distinct affinities for the enzyme. The dynamics of PKA transport to cellular organelles after stimulation may order the series of events which follow hormonal stimulation.
